A role for the mevalonate pathway in the induction of subtype cross-reactive immunity to influenza A virus by human γδ T lymphocytes
- 31 December 2010
- journal article
- Published by Elsevier BV in Cellular Immunology
- Vol. 264 (1), 71-77
- https://doi.org/10.1016/j.cellimm.2010.04.013
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (NIH) (DK-080048)
- Institute of Diabetes and Digestive and Kidney Diseases and NIH (U19 AI-057319)
This publication has 28 references indexed in Scilit:
- Cross-regulation of Signaling Pathways by Interferon-γ: Implications for Immune Responses and Autoimmune DiseasesImmunity, 2009
- Phosphoantigen‐Expanded Human γδ T Cells Display Potent Cytotoxicity against Monocyte‐Derived Macrophages Infected with Human and Avian Influenza VirusesThe Journal of Infectious Diseases, 2009
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and PresentationInternational Reviews of Immunology, 2009
- Heterosubtypic immunity to influenza A virus: where do we stand?Microbes and Infection, 2008
- Vaccinia Virus Inhibits T Cell Receptor–Dependent Responses by Human γδ T CellsThe Journal of Infectious Diseases, 2007
- Alkylamines cause Vγ9Vδ2 T-cell activation and proliferation by inhibiting the mevalonate pathwayBlood, 2006
- Murine γδ T cells in infections: beneficial or deleterious?Microbes and Infection, 2005
- Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor CellsThe Journal of Experimental Medicine, 2003
- Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cellsImmunity, 1995
- Stimulation of Human γδ T Cells by Nonpeptidic Mycobacterial LigandsScience, 1994